DR. ERIC GOTTLIEB
Conversion of biomass waste streams into sustainable performance materials that are cost-competitive with current petroleum-derived products.
DR. ANDY RAGONE
A Multispectral Imaging (MSI) Device that samples plant foliage to detect and identify stress in the leaves in less than 10 seconds by measuring multiple photosynthetic responses and key leaf responses to predict stressor type 4-6 times fast than other commercial devices.
Biotrophics is a product-based biomanufacturing company that is focusing on marketing novel proteins/peptides in the agricultural sector for various uses. As a pipeline technology company, Biotrophics is able to rapidly develop (within months) product candidates (proteins) that can be expressed in its proprietary system and produced at a commercial scale.
DENNIS PRATHER & CHRIS SCHUETZ
Technology geared at making next-generation (5G and beyond) communication systems that offer unprecedented information bandwidths as well as the ability to provide spatial isolation wherein multiple signals will not interfere. Technology also allows for "seeing" cell phone signals, meaning that a true image is rendered using cell phone signals.
DR. ADAM STAGER
An automated treatment platform
that combines proprietary Ultraviolet-C technology with robust field navigation software to replace pesticides and field labor. Tric Robotics' solution requires no input from the farmer and is the only organically accepted treatment for gray mold, one of the most yield damaging pathogens to the strawberry industry.
DR. HAJIME SAKAI
NAPIGEN uses CRISPR technology for gene editing of mitochondria and chloroplasts allowing broad application in the areas of agriculture, human health, and industrial biotechnology. Napigen technology is currently being applied to transform plant mitochondria with a goal of increasing plant yield by 15%. In addition, we are looking to apply our technology to human cell culture to develop methods to correct mutations in human cells that can lead to Parkinson’s and Alzheimer's diseases Additionally, we see an opportunity to use our technology to engineer microorganisms such as yeast to produce high-value industrial compounds efficiently in the mitochondria.